Business UpdateMay 20, 2026, 07:01 AM
Syndax to Participate in 3 Upcoming Investor Conferences
AI Summary
Syndax Pharmaceuticals announced that its Chief Executive Officer, Michael A. Metzger, along with other members of the management team, will participate in three upcoming investor conferences. These include the TD Cowen 7th Annual Oncology Innovation Summit, the Jefferies Global Healthcare Conference, and the Goldman Sachs 47th Annual Global Healthcare Conference. Live webcasts and replays of the fireside chats will be accessible through the company's investor relations website.
Key Highlights
- Syndax CEO Michael A. Metzger and management will participate in the TD Cowen 7th Annual Oncology Innovation Summit on May 27, 2026, at 1:00 p.m. ET.
- Management will attend the Jefferies Global Healthcare Conference on June 4, 2026, at 9:20 a.m. ET.
- Syndax will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, at 2:00 p.m. ET.
- Live webcasts of the fireside chats will be available in the Investor section of Syndax's website.
- Replays of the webcasts will be available for a limited time on the company's website.
Price Impact
More from SNDX